438 results on '"Saul Shiffman"'
Search Results
2. Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette
- Author
-
Nicholas I. Goldenson, Erik M. Augustson, Joey Chen, and Saul Shiffman
- Subjects
Pharmacology - Abstract
Rationale Electronic nicotine delivery systems and heated tobacco products are noncombustible alternatives for adult smokers. Evidence suggests sufficient nicotine delivery and satisfying effects are necessary to facilitate switching away from smoking; nicotine delivery varies across electronic nicotine delivery systems within limited nicotine concentrations. Objectives To assess the nicotine delivery and subjective effects of prototype JUUL2 System in two nicotine concentrations, currently-marketed US JUUL System (“JUUL”), IQOS-brand heated tobacco product, and combustible cigarettes. Methods Adult smokers (N = 40) completed a 5-arm cross-over product-use laboratory confinement study. Nicotine pharmacokinetics and subjective effects were assessed following use of: (1) JUUL2 prototype 18 mg/mL nicotine; (2) JUUL2 prototype 40 mg/mL; (3) JUUL 59 mg/mL; (4) IQOS 18 mg/g; and (5) usual brand combustible cigarette, each evaluated during ad libitum (10 min) and controlled (5 min, 10 standardized puffs) use. Results Nicotine delivery was greatest for combustible cigarettes, followed by JUUL2 prototype 40 mg/mL, IQOS, JUUL2 prototype 18 mg/mL, and JUUL 59 mg/mL. Nicotine delivery from JUUL2 prototype 18 mg/mL was significantly greater than JUUL 59 mg/mL after ad libitum use. JUUL products were significantly more satisfying and effective at reducing craving than IQOS. JUUL2 prototype 40 mg/mL was significantly more aversive than other JUUL products. Conclusions Prototype JUUL2 and JUUL 59 mg/mL products were rated higher than IQOS on subjective measures associated with switching away from smoking. The JUUL2 prototype 40 mg/mL produced aversive responses and would require modifications to be a viable product for adult smokers. Nicotine delivery and subjective responses to JUUL2 prototype 18 mg/mL suggest a product based on this prototype may facilitate increased switching among adult smokers.
- Published
- 2022
- Full Text
- View/download PDF
3. Youth Patterns of Use of Electronic Nicotine Delivery Systems (ENDS) Use, Population Assessment of Tobacco and Health (PATH) Waves 4 – 5.5
- Author
-
Arielle Selya, Saul Shiffman, and Michael Hannon
- Abstract
INTRODUCTION: Youth use of electronic nicotine delivery systems (ENDS) is a continuing concern, making it important to assess evolving patterns, especially as non-tobacco, non-menthol (NTM) flavors were withdrawn for pod-based (but not disposable) ENDS in February 2020. METHODS: Trends in past-30-day (P30D) ENDS use and smoking prevalence, usual device type, flavor (tobacco, mint/menthol, or fruit/sweet/other), and regular/last-used brand in PATH Waves 4 (2017), 4.5 (2018), 5 (2019), and 5.5 (2020) were examined. Shifts between 2019-2020 in flavor use for pods and disposables were examined. Wave 5.5 is uninformative regarding brand use because common disposable brands were not queried. RESULTS: P30D ENDS use peaked in 2019 at 8.6% of all youth, subsequently declining by nearly half to 4.5% in 2020. Meanwhile, P30D cigarette smoking declined to an all-time low (1.3%) in 2020. Within this overall decline, consumption shifted to disposable ENDS, which increased nearly 10-fold (from 5.0% to 49.2% of P30D ENDS users). Relatedly, use of fruit/sweet/other flavors remained similar overall between 2019 and 2020 (approximately 75%-80% of P30D ENDS users), but the use of these flavors became concentrated in disposable ENDS in 2020 (a 12-fold increase from 4.4% to 58.4% of fruit/sweet/other-flavor users). CONCLUSIONS: PATH results show similar trends to other US national surveys in youth ENDS trends. The removal of non-tobacco, non-menthol flavors in pod-based ENDS (while remaining available in disposables) has likely driven youth towards disposable devices, resulting in continued high use of fruit/sweet/other flavors, which are now predominant in users of disposable ENDS.
- Published
- 2023
- Full Text
- View/download PDF
4. Relative Risk Perceptions of Switching to JUUL vs. Continued Smoking and Subsequent Switching away from Cigarettes: A Longitudinal Observational Study
- Author
-
Arielle Selya and Saul Shiffman
- Abstract
Background: Evidence indicates that electronic nicotine delivery systems (ENDS) pose lower risk than cigarettes; however, many smokers misperceive ENDS to be equally ormore harmful, possibly deterring them from switching. This study examines whether relative risk perceptions of JUUL vs. smoking are associated with subsequent switching, among smokers who recently initiated JUUL use. Methods: N=16,996 current established smokers who recently purchased a JUUL Starter Kit were followed 6 times over 12 months. Relative risk perceptions were assessed using both direct and indirect measures (i.e., contrasting JUUL and smoking directly in questions, and deriving from separate absolute scales). Repeated-measures logistic regression examined switching across follow-up (no smoking in past 30 days) as a function of baseline risk perceptions, adjusting for demographics and baseline smoking behavior. Results: Perceiving JUUL as less harmful than smoking was associated with higher switching rates, using both direct (e.g., odds ratio [OR]=1.48 for “JUUL much less” vs. “more/much more harmful”) and indirect (OR=1.07, for each 10-unit increase in ratio; OR=1.51 for highest (6-100) vs. lowest (0 to ppConclusions: Smokers who perceive JUUL as less harmful than cigarettes have higher odds of switching. Future research should examine whether messaging which aligns relative risk perceptions with current evidence can facilitate switching, especially among heavier smokers.
- Published
- 2023
- Full Text
- View/download PDF
5. Comparing Adult Smokers who Switched to JUUL vs Continuing Smokers: Biomarkers of Exposure and of Potential Harm and Respiratory Symptoms
- Author
-
Saul Shiffman, Douglas R. Oliveri, Nicholas I. Goldenson, Qiwei Liang, Ryan A. Black, and Snigdha Mishra
- Abstract
Introduction: More real-world evidence on exposure to harmful and potentially harmful constituents (HPHCs) and on biological effects when cigarette smokers switch to e-cigarettes would be useful. Methods: This cross-sectional, observational study assessed adults who had smoked ≥ 10 cigarettes/day for ≥ 10 years, comparing 124 continuing cigarette smokers (Smokers) to 140 former smokers who switched to JUUL-brand e-cigarettes exclusively for ≥ 6 months (Switchers). Assessments included biomarkers of exposure (BOEs) to select HPHCs, biomarkers of potential harm (BOPHs) related to smoking-related diseases, and psychometric assessments of tobacco dependence and respiratory symptoms. Planned analyses compared geometric means, adjusted for covariates; exploratory analyses adjusted for additional covariates. Results: Nicotine was higher in Switchers, who were heavy users of JUUL. All other BOEs, including NNAL and HPMA3 (primary endpoints), were significantly lower in Switchers than Smokers. Most BOPHs (sICAM-1 [primary], and e.g., white blood cell count, MCP1, HbA1c) were significantly lower in Switchers than Smokers; HDL was significantly higher. Switchers reported significantly lower tobacco dependence and respiratory symptoms than Smokers. Conclusions: Compared to continuing smokers, smokers who switched to JUUL had substantially lower exposures to multiple HPHCs, favorable differences in markers of inflammation, endothelial function, oxidative stress, and cardiovascular risk, and less respiratory symptoms.
- Published
- 2023
- Full Text
- View/download PDF
6. What substances are adolescents vaping? Estimating nicotine-specific and marijuana-specific vaping from US national youth surveys
- Author
-
Arielle Selya, Sooyong Kim, Saul Shiffman, Joe G. Gitchell, and Floe Foxon
- Abstract
Background: The prevalence of electronic cigarette (“e-cigarettes”) use among youth has raised alarm over recent years. Vaping is usually assumed to be of nicotine, but uncertainties in survey definitions may also include non-nicotine substances which can impose different risks (particularly marijuana). The current study quantifies the proportions of nicotine-specific and marijuana-specific vaping among adolescents. Methods: Data from the Monitoring the Future (MTF) 2020 survey and National Youth Tobacco Survey (NYTS) 2021 were analyzed with respect to the substance vaped: nicotine, marijuana, or (in MTF) flavoring only. Past-30-day nicotine-specific vaping (exclusively, or also having vaped other substances) and marijuana-specific vaping were calculated. Results were also broken down by grade level, by cigarette smoking history (current, former, or never), and among frequent e-cigarette users (on 20 days out of the past 30 days). Results: Among past-30-day e-cigarette users, 14.6% (MTF) and 18.8% (NYTS) reported not vaping _any_ nicotine in the past 30 days. Marijuana use was reported by 45.7% (MTF) and 42.5% (NYTS) of past-30-day vapers. Both _nicotine_ vaping and marijuana vaping in the past 30 days were more common in current and former smokers than in never-smokers, and in frequent vapers (of any substance). Conversely, never-smokers were more commonly _exclusively_ vaping marijuana compared to current and former smokers. Conclusions: A notable proportion of self-reported past-30-day e-cigarette users reported not vaping nicotine, and nearly half of self-reported past-30-day e-cigarette users vaped marijuana. Inclusion of more detailed data capturing the variety of substances used in vaping devices is imperative for accurate public health surveillance of both nicotine and marijuana vaping among US adolescents, considering their different respective harms and regulatory mechanisms.
- Published
- 2023
- Full Text
- View/download PDF
7. The Time-Varying Effect of Alcohol Use on Cigarette Smoking Relapse Risk
- Author
-
Saul Shiffman and Sarah Dermody
- Abstract
Background: Alcohol consumption promotes lapses to smoking among smokers trying to quit, perhaps particularly among smokers with lower dependence. We assessed how the role of alcohol in lapses varies over time. Methods: This is a secondary analysis of ecological momentary assessment data collected from 159 daily smokers (mean age=43.90 (SD=10.41), 56.60% female) who drink alcohol. During the 4 weeks following initial cessation (quit >24 hours), a logistic time-varying effect model (TVEM) modeled momentary assessments of lapses and temptations to smoke compared to randomly-selected moments as a function of concurrently-assessed recent alcohol use (past 15 minutes). Time was examined continuously. Results: Recent alcohol use was associated with smoking lapses, particularly for less nicotine dependent individuals, and the association varied across time. For individuals who did not smoke within 5 minutes of waking, alcohol use became a significant predictor of lapse on Day 1 post-quit, increased in strength until Day 7, then decreased such that alcohol use was no longer associated with lapse by Day 25. For this subgroup, the associations between alcohol use and temptations were relatively stable and significant from Day 1 to 22 post-quit. Results were similar when dependence was assessed by the Nicotine Dependence Symptom Scale. Conclusions: The association between drinking and smoking lapse and temptations varies over time, peaking early in smoking abstinence and declining thereafter. This could reflect progressive relapse of most vulnerable individuals or habituation to alcohol as a smoking cue. Interventions to prevent alcohol-related lapses are essential early in the quit period.
- Published
- 2022
- Full Text
- View/download PDF
8. A New Questionnaire to Assess Respiratory Symptoms (The Respiratory Symptom Experience Scale): Quantitative Psychometric Assessment and Validation Study (Preprint)
- Author
-
Saul Shiffman, Stacey A McCaffrey, Michael J Hannon, Nicholas I Goldenson, and Ryan A Black
- Abstract
BACKGROUND Smokers often experience respiratory symptoms (eg, morning cough), and those who stop smoking, including those who do so by switching completely to electronic nicotine delivery systems (ENDS), may experience reductions in symptoms. Existing respiratory symptom questionnaires may not be suitable for studying these changes, as they are intended for patient populations, such as those with chronic obstructive pulmonary disease (COPD). OBJECTIVE This study aimed to develop a respiratory symptom questionnaire appropriate for current smokers and for assessing changes when smokers stop smoking. METHODS The Respiratory Symptom Experience Scale (RSES) was derived from existing instruments and subject matter expert input and refined through cognitive debriefing interviews (n=49). Next, for purposes of the quantitative psychometric evaluation, the RSES was administered to smokers (n=202), former smokers (no tobacco use in >6 months; n=200), and switchers (n=208, smokers who switched to ENDS for >6 months), all of whom had smoked for at least 10 years (mean age 33 years). Participants, who averaged 62 (SD 12) years of age, included 28% (173/610) with respiratory allergy symptoms and 17% (104/610) with COPD. Test-retest reliability was assessed by repeat assessment after 1 week in 128 participants. RESULTS A generalized partial credit model confirmed that the response options were ordered, and a parallel analysis using principal components confirmed that the scale was unidimensional. With allowance for 2 sets of correlated errors between pairs of items, a 1-factor graded response model fit the data. Discrimination parameters were approximately 1 or greater for all items. Scale reliability was 0.80 or higher across a broad range of severity (standardized scores −0.40 to 3.00). Test-retest reliability (absolute intraclass correlation) was good, at 0.89. RSES convergent validity was supported by substantial differences (Cohen d=0.74) between those with and without a diagnosis of respiratory disease (averaging 0.57 points, indicating that differences of this size or smaller represent meaningful differences). RSES scores also strongly differentiated those with and without COPD (d=1.52). Smokers’ RSES scores were significantly higher than former smokers’ scores (PPP=.34). CONCLUSIONS The RSES fills an important gap in the existing toolkit of respiratory symptom questionnaires; it is a reliable and valid tool to assess respiratory symptoms in adult current and former smokers, including those who have switched to noncombusted nicotine products. This suggests that the scale is sensitive to respiratory symptoms that develop in smokers and to their remission when smokers quit or switch to noncombusted nicotine products intended to reduce the harm of smoking. The findings also suggest that switching from cigarettes to ENDS may improve respiratory health.
- Published
- 2022
- Full Text
- View/download PDF
9. Population-Level Counterfactual Trend Modelling to Examine the Relationship Between Smoking Prevalence and E-Cigarette Use among US Adults
- Author
-
Floe Foxon, Arielle Selya, Joe Gitchell, and Saul Shiffman
- Subjects
Adult ,Male ,Young Adult ,Adolescent ,Vaping ,Smoking ,Prevalence ,Tobacco Smoking ,Public Health, Environmental and Occupational Health ,Humans ,Electronic Nicotine Delivery Systems - Abstract
BackgroundStudies have suggested that some US adult smokers are switching away from smoking to e-cigarette use. Nationally representative data may reflect such changes in smoking by assessing trends in cigarette and e-cigarette prevalence. The objective of this study is to assess whether and how much smoking prevalence differs from expectations since the introduction of e-cigarettes.MethodsAnnual estimates of smoking and e-cigarette use in US adults varying in age, race/ethnicity, and sex were derived from the National Health Interview Survey. Regression models were fitted to smoking prevalence trends before e-cigarettes became widely available (1999–2009) and trends were extrapolated to 2019 (counterfactual model). Smoking prevalence discrepancies, defined as the difference between projected and actual smoking prevalence from 2010 to 2019, were calculated, to evaluate whether actual smoking prevalence differed from those expected from counterfactual projections. The correlation between smoking discrepancies and e-cigarette use prevalence was investigated.ResultsActual overall smoking prevalence from 2010 to 2019 was significantly lower than counterfactual predictions. The discrepancy was significantly larger as e-cigarette use prevalence increased. In subgroup analyses, discrepancies in smoking prevalence were more pronounced for cohorts with greater e-cigarette use prevalence, namely adults ages 18–34, adult males, and non-Hispanic White adults.ConclusionPopulation-level data suggest that smoking prevalence has dropped faster than expected, in ways correlated with increased e-cigarette use. This population movement has potential public health implications.
- Published
- 2022
- Full Text
- View/download PDF
10. Examining Reactivity to Intensive Longitudinal Ecological Momentary Assessment: 12-month Prospective Study
- Author
-
Maan Isabella Cajita, Stephen L. Rathbun, Saul Shiffman, Christopher E. Kline, Christopher C. Imes, Yaguang Zheng, Linda J. Ewing, and Lora E. Burke
- Subjects
Psychiatry and Mental health ,Clinical Psychology - Abstract
Purpose To examine the association between intensive, longitudinal ecological momentary assessment (EMA) and self-reported eating behaviors. Methods Secondary analysis of the EMPOWER study—a 12-month observational study that examined the microprocesses of relapse following intentional weight loss using smartphone-administered EMA—was conducted. Participants were asked to complete four types of EMA surveys using a mobile app. For this analysis, only the number of completed random EMA surveys was used. Using linear mixed-effects modeling, we analyzed whether the number of completed random EMA surveys was associated with changes in self-reported dietary restraint, dietary disinhibition, and susceptibility to hunger measured using the Three-Factor Eating Questionnaire (TFEQ). Results During the 12-month study, 132 participants completed a mean of 1062 random EMA surveys (range: 673–1362). The median time it took for participants to complete random EMA surveys was 20 s and 90% of random EMA surveys were completed within 46 s. The number of completed random EMA surveys was not significantly associated with the TFEQ scores. Conclusions Intensive longitudinal EMA did not influence self-reported eating behaviors. The findings suggest that EMA can be used to frequently assess real-world eating behaviors with minimal concern about assessment reactivity. Nonetheless, care must be taken when designing EMA surveys—particularly when using self-reported outcome measures. Level of evidence Level III, prospective observational study.
- Published
- 2022
- Full Text
- View/download PDF
11. Higher Sales of Electronic Nicotine Delivery Systems (ENDS) in the US Are Associated with Cigarette Sales Declines, according to a Trend Break Analysis
- Author
-
Arielle Selya, Rasmus Wissmann, Saul Shiffman, Siddharth Chandra, Mark Sembower, Jonah Joselow, and Sooyong Kim
- Published
- 2022
- Full Text
- View/download PDF
12. Attribution of Use Characteristics to Electronic Cigarette Brands in the National Youth Tobacco Survey
- Author
-
Floe Foxon and Saul Shiffman
- Subjects
General Engineering - Published
- 2022
- Full Text
- View/download PDF
13. Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study
- Author
-
Russell D. Bradford, Sarah J. Farnsworth, Irene Laurora, Stephanie Sober, Hélène Guillard, Anna Glasier, and Saul Shiffman
- Subjects
Benchmarking ,Reproductive Medicine ,oral contraceptive ,Health Personnel ,Obstetrics and Gynecology ,Humans ,Prospective Studies ,adherence ,Norethindrone ,Progestins ,POP ,progestin-only pill - Abstract
ObjectivesTo measure adherence over six months of progestin-only pill (POP) use.Study DesignProspective observational cohort study measuring adherence to daily dosing and timing of dose in patients prescribed a POP, with up to six months of follow-up, conducted from January to October 2020. A pharmacy benefit manager identified potential participants with a newly prescribed POP and extended an invitation to participate. We enrolled qualified respondents by telephone, trained them to use an electronic diary to report daily whether they had taken their POP and at what time. We followed participants for up to six months. We calculated adherence to daily pill taking as the proportion of evaluable days in which a participant took a POP, and the proportion of participants reporting ≥85% adherence. We calculated adherence to same time each day as the proportion of doses taken no later than three hours after the previous dose time of day.ResultsThe user population comprised 199 participants, 154 (77.4%) of whom completed six months of follow-up. The majority (n = 170, 85.4%) were taking norethindrone. Norethindrone users reported POP intake on 22,327 (96.4%) of 23,156 evaluable days, with 155 (91.2%) participants reporting ≥85% adherence; less than half (n = 73, 42.9%) reported 100% adherence. Participants reported adherence to same time each day on 21,698 of 22,157 (97.9%) evaluable days.ConclusionsAmong participants taking a prescribed POP, participants demonstrated high adherence for daily pill taking and the same time of day, though the majority were not 100% adherent.ImplicationsThis study reports data specific to adherence among those taking a progestin-only pill (POP) in the prescription setting. Clinicians who counsel patients about POP use should be aware that majority of patients were not 100% adherent, although most report ≥85% adherence.
- Published
- 2022
- Full Text
- View/download PDF
14. Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers
- Author
-
Nicholas I. Goldenson, Patrick C Bailey, Gal Cohen, Stephanie Chan, and Saul Shiffman
- Subjects
Adult ,Nicotine ,media_common.quotation_subject ,Physiology ,Original Investigations ,Urine ,Electronic Nicotine Delivery Systems ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cigarette smoking ,medicine ,AcademicSubjects/SOC02541 ,Humans ,030212 general & internal medicine ,media_common ,Smokers ,Surrogate endpoint ,business.industry ,Smoking ,Public Health, Environmental and Occupational Health ,Cigarette smoke exposure ,Tobacco Products ,Abstinence ,chemistry ,business ,Menthol ,AcademicSubjects/MED00010 ,030217 neurology & neurosurgery ,Biomarkers ,medicine.drug ,Toxicant - Abstract
IntroductionEvidence suggests that cigarette smokers who switch to electronic nicotine delivery systems (ENDS) reduce their exposure to harmful toxicants and carcinogens. It is unclear if dual-use is associated with decreases in exposure to toxicants.MethodsThis parallel-group confinement study assessed changes in biomarkers of exposure (BOEs) over six days among healthy adult smokers who were randomized into 1 of 11 study groups: eight JUUL-brand System (JUUL) groups (4 JUUL flavors [Virginia Tobacco, Menthol, Mint, Mango] × 2 nicotine concentrations [5.0% or 3.0% by weight]); Dual-Use group used preferred JUUL flavor (5.0% nicotine) and ≤50% usual brand (UB) cigarettes/day; UB Cigarette group and one group abstained from all tobacco/nicotine product use (Abstinence group). Urine and blood analysis assessed changes in primary BOE endpoints (NNAL, 3-HPMA, MHBMA, S-PMA COHb) and secondary BOE endpoints (NNN, HMPMA, CEMA, 1-OHP, O-toluidine, 2-NA, 4-ABP) among 279 adult smokers.ResultsIn JUUL groups, median percent reductions in primary BOEs (Day 6–Baseline) were 90%–≥100% of Abstinence; there were no significant differences between JUUL groups and Abstinence. All reductions in JUUL groups were substantially and statistically significantly greater than reductions in the UB Cigarette group (ps < 0.025). Median reductions in primary BOEs in the Dual-Use group were 43%–55% of Abstinence. Similar results were observed for secondary BOEs.ConclusionThis study suggests that the use of JUUL as a complete or partial substitute (i.e., dual-use with ≥50% reduction in cigarette consumption) for combustible cigarettes can substantially reduce exposure to multiple toxins associated with cigarette smoking.ImplicationsThis study adds to the growing body of evidence supporting the utility of ENDS products as potentially reduced-harm alternatives to cigarettes for adult smokers. Adult smokers who switched completely from cigarette smoking to use of the JUUL System (“JUUL”) in two nicotine concentrations (5.0% and 3.0%) and four flavors significantly reduced their exposure to multiple classes of cigarette-related toxicants. Additionally, smokers who used JUUL and continued smoking but reduced their daily cigarette consumption by ≥50% (dual users) also significantly reduced their toxicant exposure compared to cigarette smoking.
- Published
- 2021
15. Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom
- Author
-
Shivaani Prakash, Erik M. Augustson, Yu Ding, Nicholas I. Goldenson, Cameron Hatcher, and Saul Shiffman
- Subjects
Adult ,Nicotine ,Longitudinal study ,Original Investigations ,030508 substance abuse ,Electronic Nicotine Delivery Systems ,Logistic regression ,03 medical and health sciences ,0302 clinical medicine ,Nicotine concentration ,AcademicSubjects/SOC02541 ,Humans ,Medicine ,Longitudinal Studies ,030212 general & internal medicine ,Smokers ,business.industry ,Vaping ,Smoking ,Public Health, Environmental and Occupational Health ,Tobacco Products ,Odds ratio ,United Kingdom ,United States ,Confidence interval ,Baseline characteristics ,North America ,Propensity score matching ,Smoking Cessation ,AcademicSubjects/MED00010 ,0305 other medical science ,business ,Demography ,medicine.drug - Abstract
Introduction Electronic nicotine delivery systems (ENDS) may improve public health if they facilitate smokers switching away from cigarettes. Conceptually, switching is facilitated when ENDS provide adequate nicotine delivery. Switching rates among smokers who purchased the JUUL System (“JUUL”) were compared in the United Kingdom (UK), where regulations limit nicotine concentration to 20 mg/mL versus North America (N.Am.; United States and Canada), where higher concentrations are available. Aims and Methods Adult established smokers (age ≥21, smoked ≥100 cigarettes, smoking some days or every day at baseline) who newly purchased JUUL were recruited into a longitudinal study (UK: N = 1247; N.Am.: N = 8835). Complete switching (no smoking for ≥30 days) was assessed 1, 3, and 6 months after purchase; propensity score matching (PSM) and logistic regression compared switching after adjusting for baseline characteristics. Results In both N.Am. and UK, ≥82% of participants reported using the highest JUUL nicotine concentration available (UK: 18 mg/mL; N.Am.: 59 mg/mL). Unadjusted switching rates did not differ at 1 month (17%–18%); unadjusted and adjusted rates were significantly higher in N.Am. (vs. UK) at 3 and 6 months. In the PSM sample, after additional covariate adjustment, rates were significantly higher in N.Am. (vs. UK) at 3 months (31.5% vs. 22.7%; odds ratio [95% confidence interval, CI] = 1.59 [1.25, 2.02]) and 6 months (38.0% vs. 26.0%; odds ratio [95% CI] = 1.79 [1.37, 2.35]). Conclusions These results suggest availability of ENDS in nicotine concentrations greater than 20 mg/mL may be associated with increased switching among adult smokers. Differences in smoking and ENDS use characteristics did not explain associations of location and switching; however, between-country differences may be affected by unmeasured factors. Implications Switching rates were lower among smokers who purchased the JUUL System (“JUUL”) in the UK, where regulations limit nicotine concentration to 20 mg/mL versus N.Am. (United States and Canada), where higher concentrations are available—before and after controlling for differences in smoking and ENDS use characteristics. These results suggest availability of ENDS in nicotine concentrations greater than 20 mg/mL may be associated with increased switching among adult smokers. Between-country differences may be affected by unmeasured factors; future research should consider these factors and the extent to which regulatory policy environments may explain differences in switching among adult smokers.
- Published
- 2021
- Full Text
- View/download PDF
16. Improving Retailer Compliance for Tobacco Purchases: Pilot Study Findings
- Author
-
Saul Shiffman, Shivaani Prakash, Jonah Joselow, Tengjiao Chen, Adam Zion, and Parker D Kasmer
- Subjects
Health (social science) ,Social Psychology ,business.industry ,Commerce ,Public Health, Environmental and Occupational Health ,Pilot Projects ,Access control ,Tobacco Products ,Audit ,Electronic Nicotine Delivery Systems ,Compliance (psychology) ,Test (assessment) ,Nicotine delivery ,restrict ,Humans ,Mandate ,Marketing ,business ,Database transaction - Abstract
Objectives: Those underage should not use tobacco products, including electronic nicotine delivery systems. A technologically-based solution developed by Juul Labs Inc to restrict underage access seeks to automate transactions, structurally mandate age-verification, and limit the quantity of JUUL products purchased per transaction. A pilot of this standards-based approach, referred to as RACS™ (Retail Access Control Standards), was conducted to assess efficacy. Methods: RACS was implemented at 171 stores within 3 retail chains selling tobacco products in 3 states. "Secret shopper" compliance audits, in which a mystery shopper attempted to purchase JUUL products, were conducted at participating stores before and after implementation of RACS, to test compliance with age-verification and product-quantity limits. Audit failure rates were compared pre- and post-RACS implementation to assess effectiveness. Comparisons were made overall, by chain, state, and failure type. Results: A total of 3990 audits were conducted. We found large, statistically significant reductions (p < .001) in failure rates for age-verification and compliance with product-quantity limits after implementing RACS, as compared to pre-RACS rates, declining to near zero. Conclusions: Utilizing enhanced access controls can be part of a comprehensive, evidence-based tobacco-control strategy to address underage use of all tobacco products, including JUUL.
- Published
- 2021
- Full Text
- View/download PDF
17. Smoking Trajectories of Adult Never Smokers 12 Months after First Purchase of a JUUL Starter Kit
- Author
-
Nathan M Holt and Saul Shiffman
- Subjects
Adult ,Smokers ,Health (social science) ,Social Psychology ,business.industry ,Vaping ,Smoking ,Public Health, Environmental and Occupational Health ,Non-Smokers ,Electronic Nicotine Delivery Systems ,Odds ,Never smokers ,Humans ,Medicine ,business ,Demography - Abstract
Objectives: We assessed adult never smokers' trajectories of smoking over 12 months after a first-time JUUL Starter Kit (JSK) purchase. Methods: Adult (≥ 21) never smokers (N = 3853) who purchased a JSK were recruited into an observational naturalistic study. Analyses distinguished those who had previously used ENDS (NS+E, N = 2848) from those who had not (NS-NE, N = 1005). Participants were invited to complete follow-up assessments at 1, 2, 3, 6, 9, and 12 months. "Smoking" was defined as any past-30-day smoking ("even a puff"). Results: Past-30-day smoking was reported by 5.01% of NS+E at month one, and 7.56% at month 12; for NS-NE, these were 10.23% and 12.35%. In both groups, < 5% reported smoking at both 9 and 12 months. Across follow-ups, 25%-49% of those reporting having smoked then said they were now smoking "not at all"; the remainder reported low frequency (10-12 days-per-month) and quantity (2-4 cigarettes-per-day) of smoking. Past-30-day use of JUUL remained at ≥ 80% across follow-ups. Each additional day-per-month of JUUL use decreased the odds of smoking by 1%. Conclusions: Some adult never smokers who purchased a JSK reported smoking during the suceeding year; smoking was light and intermittent. Participants who used JUUL more frequently were less likely to smoke.
- Published
- 2021
- Full Text
- View/download PDF
18. The Adult JUUL Switching and Smoking Trajectories (ADJUSST) Study: Methods and Analysis of Loss-to-Follow-up
- Author
-
Mark A. Sembower, Nicholas I. Goldenson, Saul Shiffman, Farhana Haseen, Erik M. Augustson, Christopher Russell, and Neil McKeganey
- Subjects
Adult ,Health (social science) ,Social Psychology ,business.industry ,Vaping ,Smoking ,Public Health, Environmental and Occupational Health ,Electronic Nicotine Delivery Systems ,Former Smoker ,Young Adult ,Study methods ,Humans ,Medicine ,Smoking Cessation ,Observational study ,Smoking status ,Longitudinal Studies ,business ,Follow-Up Studies ,Demography - Abstract
Objectives: The Adult JUUL System User Switching and Smoking Trajectories (ADJUSST) study assessed the smoking and JUUL use trajectories of adults who purchased JUUL. In this paper, we describe study methods, characterize the sample, and assesses potential for bias due to loss to follow-up. Methods: We entered 55,414 US adults (≥ age 21) who purchased a JUUL Starter Kit for the first time (online or at retail) in 2018 into a naturalistic, longitudinal observational study, irrespective of baseline smoking status. Participants were invited for follow-ups 1, 2, 3, 6, 9, and 12 months later, focused on assessing past-30-day smoking and JUUL use. Analyses assessed potential bias due to non-response. Results: Over 90% of participants had a history of smoking; 62.8% were past-30-day smokers; 23.3% were former smokers. Participants' average age was 30; 75% were white. Most participants (77.6%) completed some follow-ups; 25% completed all follow-ups. Baseline differences among complete responders (N = 13,729), partial responders (N = 29,252), and complete non-responders (N = 12,433) were small. When recontacted, few 12-month non-responders said their non-response was due to smoking; many reported no past-30-day smoking. Conclusions: The study may elucidate smoking trajectories of adult JUUL users. The potential for bias due to loss to follow-up in ADJUSST was limited.
- Published
- 2021
- Full Text
- View/download PDF
19. Changes in Dependence as Smokers Switch from Cigarettes to JUUL in Two Nicotine Concentrations
- Author
-
Erik M. Augustson, Saul Shiffman, Cameron Hatcher, and Nicholas I. Goldenson
- Subjects
Adult ,Nicotine ,Smokers ,Health (social science) ,Social Psychology ,business.industry ,Vaping ,Smoking ,Public Health, Environmental and Occupational Health ,Tobacco Products ,Tobacco Use Disorder ,Electronic Nicotine Delivery Systems ,medicine.disease ,Cigarette smoking ,Nicotine concentration ,medicine ,Humans ,Nicotine dependence ,business ,Demography ,medicine.drug - Abstract
Objectives: In this study, we assessed changes in dependence as smokers transitioned from cigarette smoking to exclusive use of the JUUL System ("JUUL"), contrasting users of 5.0% versus 3.0% nicotine concentration pods. Methods: Overall, 5246 adult (age ≥ 21) established smokers (> 100 cigarettes lifetime) who purchased a JUUL device completed online surveys at baseline, when smoking, and one and 3 months later; 1758 reported no past-30-day smoking ('switching') at one or both timepoints. Analyses compared dependence on cigarettes (at baseline) and JUUL (at follow-up), as assessed by the 4-item PROMIS scale (Range: 0-4). Results: Switching increased from Month 1 (18.3%) to Month 3 (28.6%); switchers at one month (Difference = 0.23) and 3 months (0.24) showed lower mean baseline cigarette dependence. Dependence decreased significantly (ps < .001) from baseline cigarette dependence to JUUL dependence at both one (from 1.82 to 1.59) and 3 months (1.97 to 1.73); changes did not significantly differ between users of 5.0% and 3.0% (ps > .43). Dependence on JUUL did not change significantly from Month 1 to Month 3. Conclusions: Dependence decreased as smokers transitioned from smoking to exclusive use of JUUL, similarly for users of both nicotine concentrations. Smokers who switch to JUUL may reduce their nicotine dependence.
- Published
- 2021
- Full Text
- View/download PDF
20. Introduction to the Special Issue on JUUL Use
- Author
-
Saul Shiffman and Erik M. Augustson
- Subjects
Consumption (economics) ,Tobacco harm reduction ,education.field_of_study ,medicine.medical_specialty ,Health (social science) ,Point of sale ,Social Psychology ,business.industry ,Public health ,Population ,Public Health, Environmental and Occupational Health ,computer.software_genre ,Nicotine ,Psychiatric comorbidity ,Nicotine delivery ,medicine ,education ,business ,computer ,Demography ,medicine.drug - Abstract
This special issue addresses key topics relating to the public health impact of the use of electronic nicotine delivery devices (ENDS), particularly JUUL-brand ENDS. Smokers smoke for nicotine, but are harmed by the byproducts of combustion. ENDS can play a role in tobacco harm reduction offering a noncombustible alternative source of nicotine for adult smokers who would otherwise continue smoking. Papers presented here estimate the prevalence of ENDS and JUUL use among young and older adults, and document the 12-month smoking trajectories of adults who purchased a JUUL Starter Kit. Overall, smoking prevalence was halved, with most smokers switching completely as dual use declined. This held for subpopulations defined by demographics and psychiatric comorbidity. For those who did not switch, most significantly reduced (50%+) their cigarette consumption. Another study reports that dependence declines as smokers switch from smoking to using JUUL. The public health potential of ENDS is undermined by use of ENDS by nonsmokers, especially underage individuals. Some smoking was reported by adult former and never smokers, with little evidence of persistent smoking, and lower risk of smoking among those using JUUL more frequently. Regarding underage use, one paper reports that technology can ensure age-verification at point of sale. Population modeling integrating impacts on diverse populations indicates that availability of ENDS is expected to avert millions of premature deaths in the US. We believe these papers make a substantial contribution to the field of tobacco science and smoking control.
- Published
- 2021
- Full Text
- View/download PDF
21. Transitions in Smoking among Adults Newly Purchasing the JUUL System
- Author
-
Robyn Gougelet, Yingying Xu, Rasmus Wissmann, Saul Shiffman, Shivaani Prakash, and Nicholas I. Goldenson
- Subjects
Adult ,Longitudinal study ,Smokers ,Health (social science) ,Social Psychology ,business.industry ,Vaping ,medicine.medical_treatment ,Smoking ,Public Health, Environmental and Occupational Health ,Population health ,Electronic Nicotine Delivery Systems ,Smoking prevalence ,Former Smoker ,United States ,Never smokers ,Sample composition ,medicine ,Humans ,Smoking cessation ,Smoking Cessation ,Smoking status ,Longitudinal Studies ,business ,Demography - Abstract
Objectives: In this study, we prospectively assessed changes in smoking a year after US adults' first-time purchase of a JUUL Starter Kit (JSK). Methods: Descriptive analyses assessed transitions in smoking status at 12 months among adult (age ≥21) JSK purchasers providing baseline and 12-month follow-up data (N = 27,164 [49.0% of baseline]), stratified by baseline smoking status. Baseline regular use of other ENDS was also considered. Results: Purchasers included baseline past 30-day smokers (65.2%), former smokers (12.0%), and never smokers (9.7%); over 90% were ever-smokers. One year later, the majority (58%) of those smoking at baseline reported no longer smoking. Former smokers or never smokers who were smoking at 12 months represented less than 2% of respondents. Former and current smokers who were regularly using other ENDS at baseline were less likely to report smoking at 12 months. Conclusions: Past 30-day smoking prevalence in a large longitudinal study of first-time JSK purchasers fell by more than half over 12 months. Analyzing the sample composition at purchase and transitions within subgroups defined by smoking status allows for a detailed understanding to help inform assessments of the population health impact of ENDS.
- Published
- 2021
- Full Text
- View/download PDF
22. Dual Use of Cigarettes and JUUL: Trajectory and Cigarette Consumption
- Author
-
Erik M. Augustson, Saul Shiffman, Marisa Greenberg, and Arielle S. Selya
- Subjects
Adult ,Consumption (economics) ,Smokers ,Health (social science) ,Social Psychology ,Time trends ,business.industry ,Vaping ,Public Health, Environmental and Occupational Health ,Electronic Nicotine Delivery Systems ,Cigarette Smoking ,Cohort ,Humans ,Medicine ,Smoking Cessation ,business ,Demography - Abstract
Objectives: Many smokers who start using ENDS engage in dual use of cigarettes and ENDS. This paper examines time trends in dual use after a JUUL Starter Kit purchase, and changes in cigarette consumption among those remaining dual users. Methods: In the ADJUSST study, a cohort of adult smokers who purchased a JUUL Starter Kit were followed naturalistically 6 times over 12 months. Trends in dual use and reported complete switching away from cigarettes (ie, no past 30-day smoking), and changes in daily average cigarettes per day from baseline at 6 and 12 months were examined. Results: Dual use declined over time as complete switching increased. By 12 months, 43.2% reported dual using, and 51.2% reported switching away from cigarettes. Among dual users, approximately 60% reduced their cigarette consumption substantially (by ≥ 50%); average reductions in cigarette consumption were > 80%. Only a small minority (3%-10%) substantially increased cigarette consumption. Conclusions: Dual use of smoking and JUUL declines over time as switching away from smoking increases. This suggests that, for most smokers, dual use is a transitional state leading to switching completely away from cigarettes. Furthermore, dual use is often marked by substantial reductions in cigarette consumption.
- Published
- 2021
- Full Text
- View/download PDF
23. Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System
- Author
-
Dish Lamichhane, Erik M. Augustson, Gem M Le, Cameron Hatcher, Arzoo Gaggar, Saul Shiffman, Shivaani Prakash, and Nicholas I. Goldenson
- Subjects
Adult ,Male ,Smokers ,Health (social science) ,Social Psychology ,business.industry ,Vaping ,Public Health, Environmental and Occupational Health ,Repeated measures design ,Mean age ,Electronic Nicotine Delivery Systems ,Logistic regression ,Smoking history ,Cigarette Smoking ,Cigarette smoking ,Humans ,Medicine ,Female ,Smoking Cessation ,Prospective Studies ,business ,Demography - Abstract
Objectives: In this study, we assessed complete switching away from cigarette smoking among adult smokers who purchased a JUUL Starter Kit (JSK). Methods: Adult (age ≥ 21) established smokers (smoked ≥ 100 lifetime cigarettes) who purchased a JSK in 2018 were invited to complete online surveys 1, 2, 3, 6, 9 and 12 months after initial JSK purchase. Point prevalence of switching (no past 30-day smoking) was assessed at each follow-up. Repeated measures logistic regression models evaluated associations of sociodemographic factors, baseline smoking characteristics and time-varying JUUL System ("JUUL") use characteristics and switching across the 12-month period. Results: Respondents (N = 17,986) were 55.0% male, 78.3% white, mean age = 32.65 years (SD = 10.81), mean baseline cigarettes/day = 11.10 (SD = 8.16). The proportion self-reporting switching increased over time: one-month (27.2%[3718/13,650]), 2-month (36.4%[4926/13,533]), 3-month (41.0%[5434/13,257]), 6-month (46.6%[5411/11,621]), 9-month (49.4%[6017/12,186]), and 12-month (51.2%[6106/11,919]); 33.1% reported switching at both 9-month and 12-month follow-ups. In prospective analyses, smokers with lower cigarette dependence, shorter smoking history, lower cigarette consumption, more frequent JUUL use, greater satisfaction from initial JUUL use, and higher JUUL dependence were significantly more likely to switch. Conclusions: Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching.
- Published
- 2021
- Full Text
- View/download PDF
24. A New Questionnaire to Assess Respiratory Symptoms (The Respiratory Symptom Experience Scale): Quantitative Psychometric Assessment and Validation Study
- Author
-
Saul Shiffman, Stacey A McCaffrey, Michael J Hannon, Nicholas I Goldenson, and Ryan A Black
- Subjects
Medicine (miscellaneous) ,Health Informatics - Abstract
Background Smokers often experience respiratory symptoms (eg, morning cough), and those who stop smoking, including those who do so by switching completely to electronic nicotine delivery systems (ENDS), may experience reductions in symptoms. Existing respiratory symptom questionnaires may not be suitable for studying these changes, as they are intended for patient populations, such as those with chronic obstructive pulmonary disease (COPD). Objective This study aimed to develop a respiratory symptom questionnaire appropriate for current smokers and for assessing changes when smokers stop smoking. Methods The Respiratory Symptom Experience Scale (RSES) was derived from existing instruments and subject matter expert input and refined through cognitive debriefing interviews (n=49). Next, for purposes of the quantitative psychometric evaluation, the RSES was administered to smokers (n=202), former smokers (no tobacco use in >6 months; n=200), and switchers (n=208, smokers who switched to ENDS for >6 months), all of whom had smoked for at least 10 years (mean age 33 years). Participants, who averaged 62 (SD 12) years of age, included 28% (173/610) with respiratory allergy symptoms and 17% (104/610) with COPD. Test-retest reliability was assessed by repeat assessment after 1 week in 128 participants. Results A generalized partial credit model confirmed that the response options were ordered, and a parallel analysis using principal components confirmed that the scale was unidimensional. With allowance for 2 sets of correlated errors between pairs of items, a 1-factor graded response model fit the data. Discrimination parameters were approximately 1 or greater for all items. Scale reliability was 0.80 or higher across a broad range of severity (standardized scores −0.40 to 3.00). Test-retest reliability (absolute intraclass correlation) was good, at 0.89. RSES convergent validity was supported by substantial differences (Cohen d=0.74) between those with and without a diagnosis of respiratory disease (averaging 0.57 points, indicating that differences of this size or smaller represent meaningful differences). RSES scores also strongly differentiated those with and without COPD (d=1.52). Smokers’ RSES scores were significantly higher than former smokers’ scores (P Conclusions The RSES fills an important gap in the existing toolkit of respiratory symptom questionnaires; it is a reliable and valid tool to assess respiratory symptoms in adult current and former smokers, including those who have switched to noncombusted nicotine products. This suggests that the scale is sensitive to respiratory symptoms that develop in smokers and to their remission when smokers quit or switch to noncombusted nicotine products intended to reduce the harm of smoking. The findings also suggest that switching from cigarettes to ENDS may improve respiratory health.
- Published
- 2023
- Full Text
- View/download PDF
25. Time-varying coefficient cumulative gap time models for intensive longitudinal ecological momentary assessment data with missingness
- Author
-
Bo Zhang, Stewart J. Anderson, Saul Shiffman, and Xiaoxue Li
- Subjects
Statistics and Probability ,021103 operations research ,Computer science ,Ecology ,Application Notes ,Inverse probability weighting ,0211 other engineering and technologies ,02 engineering and technology ,Missing data ,01 natural sciences ,body regions ,010104 statistics & probability ,Assessment data ,0101 mathematics ,Statistics, Probability and Uncertainty - Abstract
Ecological momentary assessment (EMA) studies investigate intensive repeated observations of the current behavior and experiences of subjects in real time. In particular, such studies aim to minimize recall bias and maximize ecological validity, thereby strengthening the investigation and inference of microprocesses that influence behavior in real-world contexts by gathering intensive information on the temporal patterning of behavior of study subjects. Throughout this paper, we focus on the data analysis of an EMA study that examined behavior of intermittent smokers (ITS). Specifically, we sought to explore the pattern of clustered smoking behavior of ITS, or smoking ‘bouts’, as well as the covariates that predict such smoking behavior. To do this, in this paper we introduce a framework for characterizing the temporal behavior of ITS via the functions of event gap time to distinguish the smoking bouts. We used the time-varying coefficient models for the cumulative log gap time and to characterize the temporal patterns of smoking behavior, while simultaneously adjusting for behavioral covariates, and incorporated the inverse probability weighting into the models to accommodate missing data. Simulation studies showed that irrespective of whether missing by design or missing at random, the model was able to reliably determine prespecified time-varying functional forms of a given covariate coefficient, provided the the within-subject level was small.
- Published
- 2022
26. Adult smokers’ complete switching away from cigarettes at 6, 9, and 12 months after initially purchasing a JUUL e-cigarette
- Author
-
Sooyong Kim, Saul Shiffman, and Nicholas Goldenson
- Abstract
Background: Electronic nicotine delivery systems (ENDS) have the potential to benefit public health if smokers completely switch from cigarettes to ENDS.Methods: A cohort of adult smokers (age≥21) who purchased a JUUL Starter Kit was followed for 12 months after the initial purchase. We examined factors associated with achievement and maintenance of self-reported repeated point-prevalence switching (RPPS) at three follow-ups, i.e., no past-30-day smoking at months 6, 9, and 12.Results: RPPS was reported by 21.6% of the 12,537 evaluable smokers. Smokers with lighter baseline smoking history and lower baseline cigarette dependence were more likely to report RPPS. RPPS was also associated with patterns of and responses to JUUL use: Daily use of JUUL at month 3 (OR=2.25; 95% CI=1.96–2.60) and month 6 (OR=1.81; 95% CI=1.48–2.22) was associated with higher rates of RPPS, and as were greater subjective reinforcing effects from JUUL use (assessed by the mCEQ, month-3: OR=1.70, 95% CI=1.57–1.83; month-6: OR=1.15; 95% CI=1.06–1.25). Even among smokers who did not meet the criteria of RPPS (i.e., who smoked at least once), 35.5% reported past 30-day point-prevalence switching on at least one follow-up, and their cigarette consumption was substantially reduced compared to baseline. Conclusions: Approximately one-fifth of adult smokers reported 30-day point-prevalence abstinence at 6, 9, and 12 months after purchasing JUUL. Greater use of JUUL and stronger subjective reinforcing effects were associated with non-smoking, validating the potential for ENDS to substitute for smoking, with potential for positive impacts on individual and population health.
- Published
- 2022
- Full Text
- View/download PDF
27. US adult smokers' perceived relative risk on ENDS and its effects on their transitions between cigarettes and ENDS
- Author
-
Sooyong Kim, Saul Shiffman, and Mark A. Sembower
- Subjects
Adult ,Risk ,Smokers ,Smoking ,Public Health, Environmental and Occupational Health ,Humans ,Tobacco Products ,Electronic Nicotine Delivery Systems - Abstract
Background Perceived risk reduction motivates smokers to switch to electronic nicotine delivery systems (ENDS). This research examines US smokers’ relative risk perceptions and their prospective association with various behavioral stages of switching to ENDS. Methods Data from the nationally representative, longitudinal Population Assessment of Tobacco and Health (PATH) Adult survey, Waves 1 (2014) through 5 (2019), were analyzed. We assessed the association between the perceived risk of ENDS relative to cigarettes (“less harmful” vs. “equally harmful” or “more harmful”) and 1) adoption of ENDS (among never-ENDS-using smokers), 2) complete switching to ENDS (i.e., stopping smoking, among ever-ENDS-using smokers), and 3) avoiding reversion to smoking (among smokers who had switched to ENDS), at the next wave. Results The proportion of US smokers perceiving ENDS as less harmful than cigarettes continually decreased, reaching 17.4% in Wave 5 (2019). Current smokers with such belief were more likely to adopt ENDS (aOR 1.31; 95% CI 1.15–1.50) and switch completely to ENDS (aOR 2.24; 95% CI 1.89–2.65) in the subsequent wave. Among smokers who had switched within the past year, such beliefs predicted avoidance of resumption of smoking in the next wave (aOR 0.55; 95% CI 0.33–0.93). Conclusions Smokers’ beliefs about the relative risk of ENDS compared to cigarettes had a strong and consistent association with transitions between smoking and ENDS use. Addressing the growing misperception about ENDS has the potential to contribute to public health by encouraging smokers’ switching to ENDS.
- Published
- 2022
28. Ecological momentary assessment of temptations and lapses in non-daily smokers
- Author
-
Hilary A. Tindle, Jason Mao, Donald Hedeker, Sarah M. Scholl, Stuart G. Ferguson, and Saul Shiffman
- Subjects
Adult ,Male ,Coping (psychology) ,Nicotine Chewing Gum ,Ecological Momentary Assessment ,medicine.medical_treatment ,media_common.quotation_subject ,Affective distress ,Craving ,Affect (psychology) ,Cigarette Smoking ,03 medical and health sciences ,0302 clinical medicine ,Behavior Therapy ,Recurrence ,Adaptation, Psychological ,medicine ,Humans ,media_common ,Pharmacology ,Motivation ,Smokers ,Smoking cues ,Middle Aged ,Abstinence ,medicine.disease ,030227 psychiatry ,Nicotine withdrawal ,Smoking cessation ,Female ,Smoking Cessation ,medicine.symptom ,Psychology ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
Little is known about relapse among non-daily, intermittent smokers (ITS), who have difficulty quitting, despite a lack of dependence. To analyze situations associated with temptations to smoke and smoking lapses among ITS trying to maintain abstinence. Participants were 130 initially abstinent ITS in the placebo arm of a smoking cessation study. EMA data captured participants’ situations and states in temptations (n = 976), including those that eventuated in lapses (n = 147), for up to 6 weeks. Randomly timed assessments assessed background states (n = 11,446). Participants also reported coping performed to prevent lapses. Multilevel analyses compared temptations to background situations, and lapse episodes to resolved temptations. Temptations were marked by exposure to smoking cues, including others smoking, lax smoking restrictions, and alcohol consumption, as well as more negative affect. Lapses did not differ from resolved temptations in craving intensity, but were more often associated with smoking cues and availability of cigarettes, alcohol consumption, and worse affect, and were more often attributed to good moods. Both behavioral and cognitive coping responses were associated with avoiding lapsing, but behavioral coping had much larger effects. The effects of affective distress on lapse risk were mediated by its effects on coping. Smoking cues play a major role in ITS’ temptations and lapses, perhaps indicating a degree of behavioral dependence. Affective distress also played a role in ITS lapses, undermining the idea that the affective distress seen in daily smokers’ lapses is due to nicotine withdrawal. The data reinforce the important role of coping in preventing lapses.
- Published
- 2020
- Full Text
- View/download PDF
29. Ambulatory Monitoring and Ecological Momentary Assessment
- Author
-
Thomas W. Kamarck, Mustafa al’Absi, David Epstein, Emre Ertin, Stephen Intille, Gregory Kirk, Santosh Kumar, Kenzie L. Preston, Mark Rea, Vivek Shetty, Saul Shiffman, Dan Siewiorek, Asim Smailagic, Clem Stone, and Manju Venugopal
- Published
- 2022
- Full Text
- View/download PDF
30. Changes in dependence over one year among US adults who smoke cigarettes and switched completely or partially to use of the JUUL-brand electronic nicotine delivery system
- Author
-
Saul Shiffman and Nicholas I. Goldenson
- Published
- 2023
- Full Text
- View/download PDF
31. Pharmacokinetic and Subjective Assessment of the JUUL System, Prototype JUUL2 Electronic Nicotine Delivery System in Two Nicotine Concentrations, IQOS and Combustible Cigarette
- Author
-
Saul Shiffman, Joey Chen, and Nicholas I. Goldenson
- Subjects
Nicotine ,Pharmacokinetics ,Subjective effects ,Nicotine delivery ,business.industry ,Anesthesia ,medicine ,Craving ,medicine.symptom ,business ,medicine.drug - Abstract
RATIONALE: Electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP) are noncombustible alternatives for adult smokers. Evidence suggests sufficient nicotine delivery is necessary to facilitate switching away from smoking; nicotine delivery varies across ENDS within limited nicotine concentrations. OBJECTIVES: To assess the nicotine delivery and subjective effects of currently-marketed US JUUL System (“JUUL”) ENDS, prototype JUUL2 ENDS in two nicotine concentrations, IQOS HTP and combustible cigarettes. METHODS: Adult smokers (N=40) completed a 5-arm cross-over product-use laboratory confinement study. Nicotine PK and subjective effects were assessed following use of: (1) JUUL 59mg/mL nicotine; (2) JUUL2 Prototype 18mg/mL; (3) JUUL2 Prototype 40mg/mL; (4) IQOS HTP 18mg/g; (5) usual brand (UB) cigarette, each evaluated during _ad libitum_ (10 minutes) and controlled (5 minutes, 10 standardized puffs) use. RESULTS: Nicotine delivery was greatest for UB cigarette, followed by JUUL2 Prototype 40mg/mL, IQOS, JUUL2 Prototype 18mg/mL, and JUUL 59mg/mL. Nicotine delivery from JUUL2 Prototype 18mg/mL was significantly greater than JUUL 59 mg/mL after _ad libitum_ use. JUUL products were significantly more satisfying and effective at reducing craving than IQOS. JUUL2 Prototype 40mg/mL was significantly more aversive than other JUUL products. CONCLUSIONS: Currently-marketed JUUL 59mg/mL and prototype JUUL ENDS products were rated higher than IQOS on subjective measures associated with switching away from smoking. The JUUL2 Prototype 40mg/mL produced aversive responses, and requires modifications to be a viable product for adult smokers. Nicotine delivery and subjective responses to JUUL2 Prototype 18mg/mL suggest a product based on this prototype may facilitate increased switching among adult smokers.
- Published
- 2021
- Full Text
- View/download PDF
32. Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette
- Author
-
Nicholas I, Goldenson, Erik M, Augustson, Joey, Chen, and Saul, Shiffman
- Subjects
Adult ,Nicotine ,Smokers ,Smoking ,Humans ,Tobacco Products ,Electronic Nicotine Delivery Systems - Abstract
Electronic nicotine delivery systems and heated tobacco products are noncombustible alternatives for adult smokers. Evidence suggests sufficient nicotine delivery and satisfying effects are necessary to facilitate switching away from smoking; nicotine delivery varies across electronic nicotine delivery systems within limited nicotine concentrations.To assess the nicotine delivery and subjective effects of prototype JUUL2 System in two nicotine concentrations, currently-marketed US JUUL System ("JUUL"), IQOS-brand heated tobacco product, and combustible cigarettes.Adult smokers (N = 40) completed a 5-arm cross-over product-use laboratory confinement study. Nicotine pharmacokinetics and subjective effects were assessed following use of: (1) JUUL2 prototype 18 mg/mL nicotine; (2) JUUL2 prototype 40 mg/mL; (3) JUUL 59 mg/mL; (4) IQOS 18 mg/g; and (5) usual brand combustible cigarette, each evaluated during ad libitum (10 min) and controlled (5 min, 10 standardized puffs) use.Nicotine delivery was greatest for combustible cigarettes, followed by JUUL2 prototype 40 mg/mL, IQOS, JUUL2 prototype 18 mg/mL, and JUUL 59 mg/mL. Nicotine delivery from JUUL2 prototype 18 mg/mL was significantly greater than JUUL 59 mg/mL after ad libitum use. JUUL products were significantly more satisfying and effective at reducing craving than IQOS. JUUL2 prototype 40 mg/mL was significantly more aversive than other JUUL products.Prototype JUUL2 and JUUL 59 mg/mL products were rated higher than IQOS on subjective measures associated with switching away from smoking. The JUUL2 prototype 40 mg/mL produced aversive responses and would require modifications to be a viable product for adult smokers. Nicotine delivery and subjective responses to JUUL2 prototype 18 mg/mL suggest a product based on this prototype may facilitate increased switching among adult smokers.
- Published
- 2021
33. Nightly Variation in Sleep Influences Self-efficacy for Adhering to a Healthy Lifestyle: A Prospective Study
- Author
-
Meghan Mattos, Yaguang Zheng, Jacob K Kariuki, Lora E. Burke, Eileen R. Chasens, Dara D. Mendez, Rachel W Goode, Mia I. Cajita, Stephen L. Rathbun, Saul Shiffman, Christopher E. Kline, Christopher C. Imes, Linda J. Ewing, and Andrea M. Kriska
- Subjects
Self-efficacy ,medicine.medical_specialty ,business.industry ,Sleep in non-human animals ,Self Efficacy ,Article ,Health psychology ,Weight loss ,Intervention (counseling) ,Weight Loss ,Physical therapy ,Medicine ,Humans ,Observational study ,Feeling tired ,Healthy Lifestyle ,Prospective Studies ,medicine.symptom ,business ,Prospective cohort study ,Sleep ,Applied Psychology - Abstract
BACKGROUND: Self-efficacy, or the perceived capability to engage in a behavior, has been shown to play an important role in adhering to weight loss treatment. Given that adherence is extremely important for successful weight loss outcomes and that sleep and self-efficacy are modifiable factors in this relationship, we examined the association between sleep and self-efficacy for adhering to the daily plan. Investigators examined whether various dimensions of sleep were associated with self-efficacy for adhering to the daily recommended lifestyle plan among participants (N=150) in a 12-month weight loss study. METHODS: This study was a secondary analysis of data from a 12-month prospective observational study that included a standard behavioral weight loss intervention. Daily assessments at the beginning of day (BOD) of self-efficacy and the previous night’s sleep were collected in real-time using ecological momentary assessment. RESULTS: The analysis included 44,613 BOD assessments. On average, participants reported sleeping for 6.93±1.28 hours, reported 1.56±3.54 awakenings, and gave low ratings for trouble sleeping (3.11±2.58;0: no trouble; 10: a lot of trouble) and mid-high ratings for sleep quality (6.45±2.09;0: poor; 10: excellent). Participants woke up feeling tired 41.7% of the time. Using linear mixed effects modeling, a better rating in each sleep dimension was associated with higher self-efficacy the following day (all p values
- Published
- 2021
34. Daily stress as link between disadvantage and smoking: an ecological momentary assessment study
- Author
-
Tina, Jahnel, Stuart G, Ferguson, Saul, Shiffman, and Benjamin, Schüz
- Subjects
Adult ,Male ,Ecological Momentary Assessment ,lcsh:Public aspects of medicine ,Smoking ,lcsh:RA1-1270 ,Health Status Disparities ,Middle Aged ,Social disadvantage ,Socioeconomic Factors ,EMA ,Daily stress ,Humans ,Female ,Stress, Psychological ,Research Article - Abstract
Background There is a well-established social gradient in smoking, but little is known about the underlying behavioral mechanisms. Here, we take a social-ecological perspective by examining daily stress experience as a process linking social disadvantage to smoking behavior. Method A sample of 194 daily smokers, who were not attempting to quit, recorded their smoking and information about situational and contextual factors for three weeks using an electronic diary. We tested whether socioeconomic disadvantage (indicated by educational attainment, income and race) exerts indirect effects on smoking (cigarettes per day) via daily stress. Stress experience was assessed at the end of each day using Ecological Momentary Assessment methods. Data were analyzed using random effects regression with a lower-level (2-1-1) mediation model. Results On the within-person level lower educated and African American smokers reported significantly more daily stress across the monitoring period, which in turn was associated with more smoking. This resulted in a small significant indirect effect of daily stress experience on social disadvantage and smoking when using education and race as indicator for social disadvantage. No such effects were found when for income as indicator for social disadvantage. Conclusion These findings highlight the potential for future studies investigating behavioral mechanisms underlying smoking disparities. Such information would aid in the development and improvement of interventions to reduce social inequality in smoking rates and smoking rates in general.
- Published
- 2019
- Full Text
- View/download PDF
35. Very-low-nicotine-content cigarettes and dependence among non-daily smokers
- Author
-
Saul Shiffman, Jason Mao, and Sarah M. Scholl
- Subjects
Adult ,Male ,Nicotine ,Factor score ,Toxicology ,Affect (psychology) ,Independent predictor ,law.invention ,Food and drug administration ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Nicotine dependence ,Pharmacology ,Motivation ,United States Food and Drug Administration ,business.industry ,Smoking ,Tobacco Products ,Tobacco Use Disorder ,Middle Aged ,medicine.disease ,United States ,Psychiatry and Mental health ,Female ,Smoking Cessation ,business ,030217 neurology & neurosurgery ,Demography ,medicine.drug - Abstract
Background The US Food and Drug Administration is considering reductions in the nicotine content of cigarettes to reduce smoking and tobacco dependence. A randomized study showed that even non-daily, intermittent smokers (ITS) reduced their cigarette consumption when switched to very-low-nicotine-content cigarettes (VLNCCs). This paper assesses whether switching ITS to VLNCCs results in decreased dependence and whether subsequent cigarette consumption is mediated by decreased dependence. Methods ITS randomized to VLNCCs (n = 118) or normal nicotine content cigarettes (n = 120) completed multiple measures of dependence (Fagerstrom Test of Nicotine Dependence [FTND], Nicotine Dependence Syndrome Scale [NDSS], Wisconsin Inventory of Smoking Dependence Motives [WISDM], and Hooked on Nicotine Checklist [HONC]) at Baseline and 2, 6, and 10 weeks after randomization. A principal component factor score captured common variance among these measures (except FTND). Cigarettes per day (CPD) was assessed by three convergent methods. Results Switching ITS to VLNCCs reduced dependence on all measures except the WISDM Secondary Dependence Motives and HONC. Except for the effects on the factor score, these effects of VLNCCs could be accounted for by contemporaneous CPD. Week-2 dependence measures did not prospectively predict weeks 3–4 CPD, once antecedent dependence and CPD were accounted for. "Cheating" among participants who appear to have smoked conventional cigarettes did not affect the findings. Discussion Among ITS, switching to VLNCCs results in reduced tobacco dependence. However, the reductions in dependence appear to be secondary to effects on cigarette consumption, and do not appear to be an independent predictor or cause of reduced cigarette consumption.
- Published
- 2019
- Full Text
- View/download PDF
36. Cigarette Smoking Trajectories in Adult Former Smokers Using the JUUL System
- Author
-
Lauren C Smith, Erik M. Augustson, Nathan M Holt, Saul Shiffman, Nicholas I. Goldenson, Gem M Le, and Cameron Hatcher
- Subjects
Adult ,Health (social science) ,Smokers ,Social Psychology ,business.industry ,Vaping ,Public Health, Environmental and Occupational Health ,Prevalence ,Smoking prevalence ,Electronic Nicotine Delivery Systems ,Former Smoker ,Odds ,Cigarette Smoking ,Cigarette smoking ,Cohort ,Medicine ,Humans ,Smoking Cessation ,business ,Demography - Abstract
Objective: In this study, we assessed cigarette smoking over 12 months among adult former smokers who newly purchased a JUUL Starter Kit (JSK). Methods: Prevalence of past 30-day smoking and factors associated with smoking were assessed among adult (age ≥ 21) former established smokers, stratified as recent (quitting ≤ 12 months) and long-term quitters (> 12 months), who purchased a JSK and completed ≥ 1 of 6 follow-up assessments (N = 4786). Results: Recent quitters had higher rates (16.6%-19.9%) of past 30-day smoking than long-term quitters (6.4%-9.2%) across the 12-month period; smoking prevalence did not significantly increase over time in either subgroup. Few participants (6.5% of recent quitters, 2.8% of long-term quitters) reported smoking at both 9 and 12 months, a pattern that might indicate persistent smoking. Past 30-day JUUL use remained high (≥ 87%) across the 12 months. Participants who used JUUL more frequently were less likely to smoke. Conclusions: Among former smokers who purchased JUUL, prevalence rates of smoking were low and stable across the 12-month period, suggesting there was not a growing cohort of former smokers resuming smoking. Smoking was more common in recent quitters than long-term quitters. Greater use of JUUL was associated with reduced odds of smoking resumption.
- Published
- 2021
37. Prevalence of ENDS and JUUL Use, by Smoking Status, in National Samples of Young Adults and Older Adults in the U.S
- Author
-
Shivaani Prakash, Cameron Hatcher, and Saul Shiffman
- Subjects
Adult ,Health (social science) ,Social Psychology ,Adolescent ,business.industry ,Population impact ,Vaping ,Smoking ,Public Health, Environmental and Occupational Health ,Electronic Nicotine Delivery Systems ,Former Smoker ,Smoking history ,Never smokers ,Young Adult ,Cross-Sectional Studies ,Nicotine delivery ,Prevalence ,Medicine ,Humans ,Smoking status ,Young adult ,business ,Demography - Abstract
Objectives: In this paper, we estimate the prevalence of electronic nicotine delivery systems (ENDS) and JUUL brand ENDS use among adults in the US, overall and by smoking history. Methods: We obtained 2019 cross-sectional online surveys assessing smoking, use of any ENDS, and JUUL specifically, in a national probability sample of 11,833 US adults. Data were analyzed for young adults (YA; aged 18-24) and older adults (OA; aged 25+). Results: Past 30-day ENDS prevalence was 8.0% in YA and 4.7% in OA; equivalent JUUL figures were 3.1% and 1.2%. ENDS/JUUL use was more prevalent among current and former smokers than never smokers, where prevalence was ≤ 2% (YA: 2.0%/0.9%; OA: 0.9%/0.1%). JUUL use was higher among recent (< 1 year) quitters than among long-term (≥ 1 year) quitters. Among those who had ever used both ENDS and other tobacco, strong majorities reported using other tobacco first. Among JUUL users who also had used other tobacco ≥ 95% had used other tobacco first. Conclusions: Past-30-day ENDS use (including JUUL) was ≤ 8% among young adults and ≤ 5% in older adults. Most (> 98%) ENDS and JUUL users were current or former smokers, which is relevant to assessment of the population impact of these products.
- Published
- 2021
38. Switching away from Cigarette Smoking with JUUL: Populations of Special Interest
- Author
-
Saul Shiffman, Gem M Le, and Sooyong Kim
- Subjects
Low income ,Adult ,Health (social science) ,Smokers ,Social Psychology ,business.industry ,Vaping ,Public Health, Environmental and Occupational Health ,Ethnic group ,Special Interest Group ,Electronic Nicotine Delivery Systems ,Cigarette Smoking ,Cigarette smoking ,Nicotine delivery ,Medicine ,Anxiety ,Humans ,Smoking Cessation ,Asian race ,medicine.symptom ,business ,Depression (differential diagnoses) ,Demography - Abstract
Objectives: In this study, we examined complete switching away from cigarettes across various medico-socio-demographic subpopulations of adult smokers who purchased a JUUL Starter Kit (JSK) electronic nicotine delivery system. Methods: We analyzed trajectories of smoking over 12 months in 17,986 adult smokers who purchased a JSK. Populations of special interest were characterized by race/ethnicity, income, diagnoses of potentially smoking-related illness (SRI), depression, and anxiety. Results: Across all 16 subgroups examined, a consistent pattern of trends was observed where complete switching increased, and dual-use decreased over time. Non-Hispanic Asian race/ethnicity, low income, diagnoses of potential SRI, depression, and anxiety were associated with significantly lower switching rates; however, complete switching rates at month 12 were near 50% for all groups, and surpassed the dual-use rates in all subgroups except for those with potential SRI. Conclusions: Substantial rates of complete switching were consistently achieved across all medico-socio-demographic subgroups 12 months following the purchase of the JSK. The potential benefits of switching with JUUL on smokers are likely to be experienced by a wide range of adult smokers.
- Published
- 2021
39. Ecological Momentary Assessment and Technological Advances in Clinical Care
- Author
-
Saul Shiffman, Ellen Burke Beckjord, Isabelle Morris, and Stuart G. Ferguson
- Subjects
Data collection ,Ecology ,Psychological intervention ,eHealth ,Social environment ,Confidentiality ,Psychology ,Popularity ,mHealth ,Mental health - Abstract
Ecological momentary assessment (EMA) methods provide a means by which researchers may attain highly detailed, ecologically valid, and contextually rich data on everyday experience and behavior. EMA methods are now widely used by researchers, particularly those studying health behaviors. A key reason for the popularity of EMA methods is that they allow researchers to examine both between- and within-individual differences in treatment efficacy and to explore the temporal sequences related to events of interest. Until relatively recently, EMA methods have predominately been employed as assessment and research tools. However, in recent years clinicians and researchers have begun to explore the value of real-time data collection methods as the foundation for providing tailored interventions that can respond to a patient’s behaviors, moods, social context, and geographical location. This chapter discusses how EMA data can potentially be utilized to improve the delivery of health interventions. The authors conclude that while there are clearly potential benefits of utilizing real-time data collection methods for treatment delivery, considerable work remains to ensure that EMA-based interventions are appropriate, theoretically derived, and ethical in their effects on privacy and confidentiality.
- Published
- 2020
- Full Text
- View/download PDF
40. [Commentary] Bad Data and Bad Conclusions Will Lead to Bad Policy – Implausible Claims that Vaping Increases COVID-19 Risk for Youth and Young Adults
- Author
-
Joe G. Gitchell, David Sweanor, Bethea Kleykamp, Raymond Niaura, K. Michael Cummings, David B. Abrams, and Saul Shiffman
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,General Engineering ,medicine ,Young adult ,Suspect ,Psychiatry ,Psychology - Abstract
In this brief peer review, we argue that the data reported by Gaiha et al (https://doi.org/10.1016/j.jadohealth.2020.07.002) regarding associations between vaping and COVID-19 testing are so suspect that any conclusions drawn from it cannot be relied upon. We discuss six main areas of concern and conclude that the paper should be retracted.
- Published
- 2020
- Full Text
- View/download PDF
41. Ambulatory Assessment
- Author
-
Stuart G. Ferguson, Tina Jahnel, Katherine Elliston, and Saul Shiffman
- Published
- 2020
- Full Text
- View/download PDF
42. Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users
- Author
-
Geoffrey M. Curtin, Mark A. Sembower, Janine L. Pillitteri, Saul Shiffman, and Michael R. Polster
- Subjects
medicine.medical_specialty ,lcsh:Social pathology. Social and public welfare. Criminology ,Research paper ,Risk perceptions ,media_common.quotation_subject ,lcsh:BF1-990 ,Medicine (miscellaneous) ,Health benefits ,lcsh:HV1-9960 ,Tobacco users ,Perception ,Environmental health ,Medicine ,Snus ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,media_common ,business.industry ,Addiction ,Public health ,Modified-risk ,Comprehension ,Psychiatry and Mental health ,Clinical Psychology ,lcsh:Psychology ,Smokeless tobacco ,business - Abstract
Highlights • Comprehension and risk perceptions of modified-risk messages for snus were tested. • Modified-risk information communicated reduced risk of snus compared to cigarettes. • The modified-risk information was understood by majorities of respondents. • Most perceived snus to have considerable risk, although less risk than cigarettes. • Providing modified-risk information about snus could facilitate smokers switching., Introduction Snus, a low nitrosamine smokeless tobacco product, presents less risks to health than cigarettes. Effectively communicating such risk information could facilitate smokers switching completely to snus, thereby benefiting public health. Methods This study assessed comprehension and perceptions of modified-risk information regarding snus. Adult cigarette smokers, former tobacco users, and never tobacco users (N = 3,922) from a US internet panel viewed an advertisement stating that smokers who switched completely to snus could greatly reduce risk of lung cancer, respiratory disease, heart disease, and oral cancer. Respondents answered questions regarding the modified-risk information and rated perceived risks of snus relative to cigarettes and other smokeless tobacco products. Results Across the four diseases mentioned in the advertisement, most respondents (49.7%–68.6%, across tobacco user groups) understood that snus presents less risk than cigarettes but is not completely safe. Some indicated snus presents the same risk as cigarettes; this was highest for oral cancer (33.7%–42.02%) and lowest for lung cancer (15.4%–23.1%) and respiratory disease (15.6%–23.4%). Majorities understood snus is addictive (77.7%–87.9%), quitting all tobacco is the best option for smokers (83.6%–93.1%), and non-users of tobacco should not use snus (80.4%–87.8%). Only 2.1%–5.8% indicated smokers would receive a health benefit if they continued to smoke while using snus. Conclusions The modified-risk information, conveying that snus presents less risk than cigarettes but is not completely safe, was understood by majorities of respondents. Differential risk beliefs across diseases suggest responses were shaped not only by the modified-risk information, but also by intuitions and pre-existing beliefs about tobacco products.
- Published
- 2020
43. Differences in switching away from cigarettes and JUUL use characteristics among adult menthol and nonmenthol smokers who purchased the JUUL System
- Author
-
Nicholas I, Goldenson, Erik M, Augustson, and Saul, Shiffman
- Subjects
Adult ,Pharmacology ,Menthol ,Psychiatry and Mental health ,Smokers ,Humans ,Smoking Cessation ,Pharmacology (medical) ,Tobacco Products ,Electronic Nicotine Delivery Systems ,Toxicology - Abstract
Studies have assessed switching away from cigarettes among adult smokers who use electronic nicotine delivery systems (ENDS), but there is little data assessing differences in likelihood of switching or ENDS use characteristics by menthol smoking.Adult (age ≥ 21) established smokers who purchased a JUUL Starter Kit (N = 15,036) completed baseline and 1-, 2-, 3-, 6-, 9- and 12-month assessments. Switching (no past-30-day cigarette smoking) and flavor use were assessed at each follow-up. Repeated-measure logistic regression models evaluated association of menthol smoking and switching across 1 year.Across the 6 follow-ups, more menthol smokers primarily used Menthol/Mint-flavored JUULpods (53.8%) than nonmenthol smokers (22.9%). Only 6.4% of menthol smokers primarily used Tobacco flavors (vs. 25.9% of nonmenthol smokers). Across all follow-ups menthol smokers (41.2% of sample) were more likely to switch than nonmenthol smokers (42.6% vs. 38.8%: OR [95% CI] = 1.17 [1.11, 1.23]); this association remained significant after adjustment for sociodemographic, smoking and JUUL use covariates (aOR [95% CI] = 1.13 [1.05, 1.21]). Nonmenthol smokers, but not menthol smokers, were significantly more likely to switch when primarily using Menthol/Mint-flavored (vs. Tobacco-flavored) JUULpods (aOR [95% CI] = 1.14 [1.04, 1.25]). Differences in baseline smoking characteristics between menthol and nonmenthol smokers were small in magnitude.Adult menthol (vs. nonmenthol) smokers using JUUL were more likely to switch. More than twice as many menthol (vs. nonmenthol) smokers primarily used Menthol/Mint-flavor JUULpods; few menthol smokers used tobacco flavors. Given these pronounced differences in flavor preferences, availability of ENDS in menthol flavors may be particularly important for menthol smokers, but may also benefit some nonmenthol smokers.
- Published
- 2022
- Full Text
- View/download PDF
44. Knowledge of dosing directions among current users of acetaminophen-containing medications
- Author
-
Judith P. Kelly, Mary Kathryn Malone, Saul Shiffman, David Kaufman, Rachel B. Weinstein, and Deena R. Battista
- Subjects
Male ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,MEDLINE ,Nonprescription Drugs ,Pharmacology (nursing) ,Pharmacy ,030226 pharmacology & pharmacy ,Odds ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Dosing ,Medical prescription ,Acetaminophen ,Drug Labeling ,Pharmacology ,Active ingredient ,Internet ,business.industry ,Outcome measures ,Analgesics, Non-Narcotic ,Drug Combinations ,Concomitant ,Emergency medicine ,Female ,Drug Overdose ,business ,medicine.drug - Abstract
Objectives Users should know the active ingredients and dosing directions to optimize the safe use of acetaminophen-containing medications. The aim of this work was to examine knowledge of acetaminophen-containing medication directions among current users. Design, setting, and participants An Internet panel diary study (2012-2016) of 1-week usage of acetaminophen medications (over-the-counter [OTC] and prescription), recorded daily; 9629 participants. Users were asked about ingredients of medications taken; specific dosing instructions were asked for each OTC medication taken. Subjects were considered to be correct only if an accurate response was provided for all of the medications they used. Outcome measures Analyses examined prevalence of several aspects of knowledge and their relation to the corresponding deviations from directions. Knowledge that acetaminophen was an ingredient was compared between medication types. Results Two-thirds of 5161 participants who used only 1 acetaminophen medication knew the ingredient; the proportion was almost halved in 4468 users of 2 or more. Ingredient knowledge was highest for single-ingredient medications (74%); for combination medications it ranged from 39% (cough or cold) to 61% (sleep or other non-pain). About one-third knew the prohibition against concomitant use of multiple acetaminophen medications; 85% knew the maximum one-time OTC dose, but only 47% knew the minimum interval between doses. Correct knowledge was inversely associated with violating the relevant label directions; in particular, knowing the one-time dose decreased the odds of taking too much at one time fivefold. Knowing both the ingredient and the concomitant use prohibition decreased the odds of concomitant use by 50%. Conclusions Knowledge of directions for safe use of acetaminophen-containing medications is poor, and its deficiency is associated with corresponding deviations from label instructions. This study demonstrates a need for education about safe use of acetaminophen-containing medications, particularly for combination products.
- Published
- 2018
- Full Text
- View/download PDF
45. Momentary smoking context as a mediator of the relationship between SES and smoking
- Author
-
Tina Jahnel, Stuart G. Ferguson, Saul Shiffman, Benjamin Schüz, and Johannes Thrul
- Subjects
Adult ,Male ,Mediation (statistics) ,Ecological Momentary Assessment ,Medicine (miscellaneous) ,Context (language use) ,Toxicology ,Article ,Electronic diary ,03 medical and health sciences ,0302 clinical medicine ,Humans ,030212 general & internal medicine ,Situational ethics ,Socioeconomic status ,030505 public health ,Operationalization ,Smoking ,Reproducibility of Results ,Educational attainment ,Psychiatry and Mental health ,Clinical Psychology ,Social Class ,Assessment methods ,Female ,Smoking Cessation ,0305 other medical science ,Psychology ,Demography - Abstract
There is a well-established socioeconomic gradient in smoking behavior: those with lower socioeconomic status smoke more. However, much less is known about the mechanisms explaining how SES is linked to smoking. This study takes a social-ecological perspective by examining whether socioeconomic status affects smoking behavior by differential exposure to places where smoking is allowed. Exposure to smoking restrictions was assessed in real-time using Ecological Momentary Assessment methods. A sample of 194 daily smokers, who were not attempting to quit, recorded their smoking and information about situational and contextual factors for three weeks using an electronic diary. We tested whether a smoker's momentary context mediated the relationship between socioeconomic status (educational attainment) and cigarettes smoked per day (CPD). Momentary context was operationalized as the proportion of random assessments answered in locations where smoking was allowed versus where smoking was not allowed. Data were analysed using multilevel regression (measurements nested within participants) with a lower level mediation model (2-1-1 mediation). Although no significant direct effect of SES on CPD were observed, there was a significant indirect effect of SES on CPD via the momentary context. Compared to participants with higher education, lower educated participants were more likely to encounter places where smoking was allowed, and this in turn, was associated with a higher number of CPD. These findings suggest that SES is associated with smoking at least partially via differential exposure to smoking-friendly environments, with smokers from lower SES backgrounds accessing more places where smoking is allowed. Implications for current smoke-free legislation are discussed.
- Published
- 2018
- Full Text
- View/download PDF
46. Psychometric Evaluation of the Relapse Situation Efficacy Questionnaire in a Weight Loss Treatment Study
- Author
-
Qianheng Ma, Yang Yu, Lora E. Burke, Jeffrey M. Rohay, Saul Shiffman, Ran Sun, and Susan M. Sereika
- Subjects
Adult ,Male ,Predictive validity ,Health (social science) ,Psychometrics ,Social Psychology ,Concurrent validity ,Body Mass Index ,Cronbach's alpha ,Recurrence ,Surveys and Questionnaires ,Bayesian multivariate linear regression ,Weight Loss ,Humans ,Obesity ,Public Health, Environmental and Occupational Health ,Reproducibility of Results ,Construct validity ,Middle Aged ,Overweight ,Self Efficacy ,Exploratory factor analysis ,Convergent validity ,Female ,Psychology ,Clinical psychology - Abstract
Objectives We assessed the psychometric properties of the Relapse Situation Efficacy Questionnaire - Weight (RSEQ-W) including internal consistency reliability, criterion-related validity (concurrent and predictive validity) and construct validity (convergent validity and factor analysis). Methods We administered the RSEQ-W at baseline, and at 6 and 12 months in a 12-month prospective behavioral weight loss study. Spearman correlations were used to examine the convergent and concurrent validity; multivariate linear regression was used to assess the predictive validity; exploratory factor analysis was conducted using principal component analysis. Results The sample (N = 148) was 90.5% women and 81.1% white with a mean body mass index of 34.1 ± 4.6 kg/m2. The RSEQ-W showed good internal consistency (Cronbach's α = .95) and convergent validity (r = .69). PCA results revealed that the 31 items can be factored into 6 components negative affect, positive affect, social occasions, low focus, activity andlack of energy. Conclusion These results provide preliminary support for the reliability and validity of the RSEQ-W. Future work needs to apply RSEQ-W in studies with larger and more diverse samples and also consider adding more items to the factor lack of energy.
- Published
- 2018
- Full Text
- View/download PDF
47. Interaction between ethnicity and smoker type with dependence: A comparison of daily and intermittent African American and Caucasian smokers
- Author
-
Jessica Cheng, Sarah M. Scholl, Wendy C. King, and Saul Shiffman
- Subjects
Adult ,Male ,Ethnic group ,Medicine (miscellaneous) ,Daily smoking ,White People ,Article ,Nicotine ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Nicotine dependence ,African american ,Motivation ,Smokers ,030505 public health ,Multivariable linear regression ,Extramural ,Smoking ,Tobacco Use Disorder ,Middle Aged ,medicine.disease ,Black or African American ,Psychiatry and Mental health ,Clinical Psychology ,Female ,0305 other medical science ,Psychology ,Demography ,medicine.drug - Abstract
INTRODUCTION: Ethnic differences in smoking patterns and dependence have been observed between Caucasian and African American smokers: African Americans who smoke are more likely to be intermittent smokers (ITS), and among daily smokers (DS) consume fewer cigarettes, yet report more dependence. METHODS: Participants’ (N=482, 67% Caucasian, 54% ITS) dependence was assessed by Primary and Secondary Dependence subscales of the Wisconsin Inventory of Smoking Dependence Motives, the Nicotine Dependence Syndrome Scale, the Hooked on Nicotine Checklist, the Fagerstrom Test of Nicotine Dependence, and time to first cigarette after waking. We tested associations with dependence for ethnicity, smoker type, and an ethnicity by smoker type interaction, using multivariable linear regression, with adjustment for age, sex and education. Additional models adjusted for cigarettes per day and history of daily smoking. RESULTS: There was a significant interaction between ethnicity and smoker type for five of six measures of dependence (each scale assessed separately), such that African American ITS reported more dependence than Caucasian ITS, whereas dependence did not differ by ethnicity among DS. African American ITS smoked more cigarettes per day and were more likely to have a history of daily smoking than Caucasian ITS; after further adjustments for these differences, there were no significant interactions of ethnicity and smoker type for any measure. CONCLUSIONS: Among DS, dependence did not differ by race. African American ITS were more dependent than Caucasian ITS; this difference was explained by higher cigarette consumption and a higher proportion converted from DS to ITS among African Americans vs. Caucasians.
- Published
- 2018
- Full Text
- View/download PDF
48. Exposure to workplace smoking bans and continuity of daily smoking patterns on workdays and weekends
- Author
-
Michael Stephen Dunbar, Saul Shiffman, and Siddharth Chandra
- Subjects
Adult ,Male ,Time Factors ,Metabolic Clearance Rate ,Ecological Momentary Assessment ,030508 substance abuse ,Medicine (miscellaneous) ,Daily smoking ,Toxicology ,Article ,Cigarette Smoking ,Smoking behavior ,03 medical and health sciences ,0302 clinical medicine ,Time of day ,Business hours ,Environmental health ,Humans ,Medicine ,030212 general & internal medicine ,Cotinine ,Workplace ,Generalized estimating equation ,Smoke ,business.industry ,Tobacco control ,Tobacco Use Disorder ,Middle Aged ,Organizational Policy ,Psychiatry and Mental health ,Clinical Psychology ,Smoke-Free Policy ,Female ,Smoking restrictions ,0305 other medical science ,business - Abstract
INTRODUCTION: Individuals may compensate for workplace smoking bans by smoking more before or after work, or escaping bans to smoke, but no studies have conducted a detailed, quantitative analysis of such compensatory behaviors using real-time data. METHODS: 124 daily smokers documented smoking occasions over 3 weeks using ecological momentary assessment (EMA), and provided information on real-world exposure to smoking restrictions and type of workplace smoking policy (full, partial, or no bans). Mixed modeling and generalized estimating equations assessed effects of time of day, weekday (vs weekend), and workplace policy on mean cigarettes per hour (CPH) and reports of changing location to smoke. RESULTS: Individuals were most likely to change locations to smoke during business hours, regardless of work policy, and frequency of EMA reports of restrictions at work was associated with increased likelihood of changing locations to smoke (OR=1.11, 95% CI 1.05 – 1.16; p < .0001). Workplace smoking policy, time block, and weekday/weekend interacted to predict CPH (p < .01), such that individuals with partial work bans –but not those with full bans - smoked more at night (9pm – bed) on weekdays compared to weekends. CONCLUSIONS: There was little evidence that full bans interfered with subjects' smoking during business hours across weekdays and weekends. Smokers largely compensate for exposure to workplace smoking bans by escaping restrictions during business hours. Better understanding the effects of smoking bans on smoking behavior may help to improve their effectiveness and yield insights into determinants of smoking in more restrictive environments.
- Published
- 2018
- Full Text
- View/download PDF
49. Prevalence of exceeding maximum daily dose of paracetamol, and seasonal variations in cold-flu season
- Author
-
Judith P. Kelly, David Kaufman, Deena R. Battista, Mary Kathryn Malone, Saul Shiffman, and Rachel B. Weinstein
- Subjects
Pharmacology ,medicine.medical_specialty ,business.industry ,Prevalence ,Odds ratio ,030226 pharmacology & pharmacy ,Confidence interval ,Acetaminophen ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Internal medicine ,Epidemiology ,medicine ,Flu season ,Pharmacology (medical) ,030212 general & internal medicine ,Dosing ,business ,medicine.drug - Abstract
Aims To estimate prevalence of excess intake of paracetamol and investigate seasonal variations therein. Methods Between 2011 and 2016, 14 481 US adults who used paracetamol in the preceding 30 days were sampled from national online panels and completed a detailed online daily diary of paracetamol medication use for 7 days. Respondents were not told that the study concerned paracetamol. Cold/flu season (CFS), identified using Google Trends data, was contrasted to off-season in symptoms, use of paracetamol medications, and consumption exceeding 4 g (the recommended daily maximum). Results Overall, 6.3% [95% confidence interval: 5.9-6.7%] of users exceeded 4 g on at least one day; 3.7% [3.5-3.8%] of usage days exceeded 4 g. Cold/flu symptoms were more likely to be experienced and treated with paracetamol in CFS than off-season. Paracetamol users were more likely to exceed 4 g during CFS (6.5% vs. 5.3%; odds ratio = 1.24, 1.04-1.48); days exceeding 4 g also increased (3.9% vs. 2.8%; odds ratio = 1.37, 1.11-1.69). This was not due to differences in characteristics of individuals using paracetamol in CFS, but primarily to increased use of over-the-counter combination medications designed to treat upper respiratory cold/flu symptoms (33.2% of usage days in CFS vs. 24.8% in off-season; odds ratio = 1.58, 1.46-1.72). When such medications were omitted, there was no statistically significant seasonal variation in exceeding 4 g. Conclusions Paracetamol use and over-dosing increases in CFS, primarily due to increased use of over-the-counter combinations treating upper respiratory cold/flu symptoms. Pharmacists should warn users to follow labelled dosing directions, especially during CFS.
- Published
- 2018
- Full Text
- View/download PDF
50. Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users
- Author
-
Mary Kathryn Malone, David Kaufman, Judith P. Kelly, Rachel B. Weinstein, Deena R. Battista, and Saul Shiffman
- Subjects
Adult ,Male ,medicine.medical_specialty ,Epidemiology ,Pain ,Ibuprofen ,Nonprescription Drugs ,030204 cardiovascular system & hematology ,Physical function ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Patient Education as Topic ,Surveys and Questionnaires ,Internal medicine ,Prevalence ,medicine ,Humans ,Pharmacology (medical) ,Medical history ,Prospective Studies ,030212 general & internal medicine ,Dosing ,Prospective cohort study ,Nonsteroidal ,Dose-Response Relationship, Drug ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Middle Aged ,Pharmacoepidemiology ,chemistry ,Female ,business ,medicine.drug - Abstract
Purpose Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective and very commonly used, but also have side effects. We determined prevalence of NSAID dosing exceeding the daily limit (EDL) and identified related user characteristics and dosing patterns among current ibuprofen users. Methods Online 1-week diary study of 1326 ibuprofen users. NSAIDs were identified by list-based prompting; respondents were not required to know their medications were NSAIDs. Details of hourly use were recorded by respondents daily. Deviations from dosing directions were programmatically determined afterwards. An exit survey obtained information on demographics, medical history, physical and mental health status, attitudes regarding label reading and dosing behavior, and knowledge of product label instructions. Results Most diary users (90%) took over-the-counter ibuprofen during the week; 37% also took non-ibuprofen NSAIDs. Most did not recognize all products taken as NSAIDs. EDL occurred among 11% of users for ibuprofen, 4% of users for other NSAIDs, and on 9.1% of NSAID usage days. EDL was associated with deviations from detailed dosing directions, particularly exceeding the 1-time dose, which occurred more often with medications with 1-pill doses. Personal characteristics associated with EDL included male sex, ongoing pain, poor physical function, daily smoking, having the attitudes of “choosing my own dose” and not starting with the lowest dose, and poor knowledge of the recommended 1-time and 24-hour doses. Conclusions The prevalence of EDL among NSAID users is nontrivial, and it is associated with potentially modifiable factors. Educating consumers about NSAIDs and their dosing directions could reduce excess dosing.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.